chr16-1207298-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_021098.3(CACNA1H):c.2931C>T(p.Asn977Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000429 in 1,610,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000036 ( 0 hom. )
Consequence
CACNA1H
NM_021098.3 synonymous
NM_021098.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.367
Publications
0 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 16-1207298-C-T is Benign according to our data. Variant chr16-1207298-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 529644.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.367 with no splicing effect.
BS2
High AC in GnomAd4 at 16 AD gene.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.2892C>T | p.Asn964Asn | synonymous_variant | Exon 14 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.2892C>T | p.Asn964Asn | synonymous_variant | Exon 14 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.2931C>T | p.Asn977Asn | synonymous_variant | Exon 14 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*844C>T | non_coding_transcript_exon_variant | Exon 14 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*2378C>T | non_coding_transcript_exon_variant | Exon 13 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.2931C>T | non_coding_transcript_exon_variant | Exon 14 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000640028.1 | n.*844C>T | 3_prime_UTR_variant | Exon 14 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*2378C>T | 3_prime_UTR_variant | Exon 13 of 34 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152040Hom.: 0 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
16
AN:
152040
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000331 AC: 8AN: 241824 AF XY: 0.0000228 show subpopulations
GnomAD2 exomes
AF:
AC:
8
AN:
241824
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1458110Hom.: 0 Cov.: 33 AF XY: 0.0000345 AC XY: 25AN XY: 725094 show subpopulations
GnomAD4 exome
AF:
AC:
53
AN:
1458110
Hom.:
Cov.:
33
AF XY:
AC XY:
25
AN XY:
725094
show subpopulations
African (AFR)
AF:
AC:
14
AN:
33416
American (AMR)
AF:
AC:
1
AN:
44288
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26030
East Asian (EAS)
AF:
AC:
2
AN:
39616
South Asian (SAS)
AF:
AC:
2
AN:
85758
European-Finnish (FIN)
AF:
AC:
0
AN:
52578
Middle Eastern (MID)
AF:
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
AC:
31
AN:
1110404
Other (OTH)
AF:
AC:
3
AN:
60260
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000105 AC: 16AN: 152040Hom.: 0 Cov.: 30 AF XY: 0.0000943 AC XY: 7AN XY: 74252 show subpopulations
GnomAD4 genome
AF:
AC:
16
AN:
152040
Hom.:
Cov.:
30
AF XY:
AC XY:
7
AN XY:
74252
show subpopulations
African (AFR)
AF:
AC:
12
AN:
41410
American (AMR)
AF:
AC:
0
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5160
South Asian (SAS)
AF:
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
AC:
4
AN:
67988
Other (OTH)
AF:
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Dec 23, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Feb 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.